Within the open-label basket trial, patients with two copies of one of two high-risk APOL1 gene variants will receive MZE829.
The IRST Block II enhances ‘situational awareness by supplementing air-to-air detection and track capabilities, and autonomously or in combination with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback